C25.4

Clinical Causes: Genetic mutations or alterations in pancreatic cells Family history of pancreatic or other endocrine tumors Chronic pancreatitis or long-standing pancreatic inflammation Lifestyle factors, such as smoking and obesity Exposure to certain chemicals or environmental toxins Other genetic syndromes, such as Multiple Endocrine Neoplasia (MEN)

Key Symptoms: Unexplained weight loss Upper abdominal pain or discomfort Jaundice (yellowing of the skin and eyes) Nausea and vomiting Loss of appetite New onset of diabetes or changes in blood sugar levels Digestive problems, such as indigestion or stools that are fatty or pale Feelings of weakness or fatigue

Diagnosis Path: Diagnosing malignant endocrine pancreatic tumors involves several methods to accurately identify and assess the extent of the disease. These may include: - Imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), or endoscopic ultrasound - Blood tests to detect tumor markers or hormone levels - Biopsy procedures to obtain tissue samples for microscopic examination - Additional tests, like somatostatin receptor scintigraphy, to evaluate tumor spread Early diagnosis can improve treatment options and outcomes, making prompt medical consultation critical if symptoms are present.

Treatment Protocols: Treatment strategies for malignant neoplasm of the endocrine pancreas depend on various factors, including tumor size, location, stage, and the patient’s overall health. Common approaches include: - Surgical removal of the tumor or affected pancreatic tissue, potentially extending to nearby lymph nodes - Chemotherapy to target cancer cells and slow progression - Targeted therapies or medication to manage hormone-related symptoms or tumor growth - Radiation therapy, though less common, may be considered in certain cases - Supportive care to address symptoms and improve quality of life A multidisciplinary team of specialists typically coordinates the treatment plan to optimize patient outcomes.